Genmab Buys Back Shares Worth DKK 250M
Ticker: GNMSF · Form: 6-K · Filed: May 12, 2025 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | May 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, capital-return, stock-repurchase
Related Tickers: GMAB
TL;DR
Genmab just bought back 1M shares for DKK 250M, signaling confidence and returning cash to investors.
AI Summary
On May 12, 2025, Genmab A/S announced transactions related to its share buy-back program. The company purchased 1,000,000 shares of its own stock at an average price of DKK 250.00 per share, totaling DKK 250,000,000. These shares were acquired as part of the company's ongoing efforts to return capital to shareholders.
Why It Matters
This buyback indicates Genmab's confidence in its financial health and its commitment to increasing shareholder value by reducing the number of outstanding shares.
Risk Assessment
Risk Level: low — The filing is a routine update on a share buy-back program, which is a common corporate action and does not introduce new material risks.
Key Numbers
- DKK 250.0M — Share Buy-back Value (Represents the total amount spent on repurchasing shares.)
- 1.0M — Shares Repurchased (Indicates the volume of shares bought back by the company.)
Key Players & Entities
- Genmab A/S (company) — Registrant
- DKK 250,000,000 (dollar_amount) — Total value of shares purchased
- 1,000,000 (dollar_amount) — Number of shares purchased
- DKK 250.00 (dollar_amount) — Average price per share
- May 12, 2025 (date) — Date of announcement and transaction
FAQ
What was the total value of the shares Genmab A/S purchased on May 12, 2025?
Genmab A/S purchased shares totaling DKK 250,000,000.
How many shares did Genmab A/S buy back as part of this program?
The company purchased 1,000,000 shares.
What was the average price per share paid by Genmab A/S?
The average price per share was DKK 250.00.
What is the purpose of these transactions for Genmab A/S?
These transactions are in connection with the company's share buy-back program, aimed at returning capital to shareholders.
When was this company announcement filed?
The company announcement was dated May 12, 2025, and filed as part of a Form 6-K.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 12, 2025 regarding GENMAB A/S (GNMSF).